Clover Health Investments, Corp. /De (CLOV) — SEC Filings
Clover Health Investments, Corp. /De (CLOV) — 45 SEC filings. Latest: 10-Q (May 8, 2026). Includes 31 8-K, 7 10-Q, 3 SC 13G/A.
View Clover Health Investments, Corp. /De on SEC EDGAR
Overview
Clover Health Investments, Corp. /De (CLOV) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 1, 2026: Clover Health Investments, Corp. filed an 8-K on April 1, 2026, reporting events related to Item 5.02 (Departure/Election of Officers/Directors) and Item 8.01 (Other Events). The filing date indicates a report submitted on March 30, 2026.
Sentiment Summary
Across 45 filings, the sentiment breakdown is: 2 bearish, 42 neutral, 1 mixed. The dominant filing sentiment for Clover Health Investments, Corp. /De is neutral.
Filing Type Overview
Clover Health Investments, Corp. /De (CLOV) has filed 7 10-Q, 31 8-K, 2 DEF 14A, 2 10-K, 3 SC 13G/A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (45)
Risk Profile
Risk Assessment: Of CLOV's 37 recent filings, 2 were flagged as high-risk, 17 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $496,650,000 |
| Net Income | -$24,377,000 |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $190,055,000 |
| Operating Margin | N/A |
| Total Assets | $559,659,000 |
| Total Debt | N/A |
Key Executives
- Andrew Toy
- Peter Kuipers
- Dr. David M. Gollaher
- Dr. Andrew M. Wilson
Industry Context
The health insurance industry is highly competitive and heavily regulated, with a constant focus on managing medical costs and member acquisition. Trends include a shift towards value-based care models and the increasing use of technology to improve efficiency and patient outcomes. Companies like Clover Health are navigating these dynamics by leveraging technology platforms to enhance care delivery and reduce costs.
Top Tags
sec-filing (9) · financial-reporting (8) · corporate-governance (5) · Healthcare (4) · disclosure (4) · financials (4) · 8-K (4) · regulation-fd (4) · 8-k (3) · executive-changes (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC Accession Number | 0001801170-26-000080 | Unique identifier for this specific filing |
| Net Loss (Q3 2025) | $24.377M | Increased from $9.155M in Q3 2024, indicating widening losses. |
| Total Revenues (Q3 2025) | $496.650M | Up 50.0% from $330.986M in Q3 2024, driven by premiums. |
| Premiums Earned, Net (Q3 2025) | $479.128M | Increased from $322.579M in Q3 2024, a primary revenue driver. |
| Net Medical Claims Incurred (Q3 2025) | $423.473M | Increased 69.5% from $249.774M in Q3 2024, outpacing revenue growth. |
| Cash and Cash Equivalents (Sep 30, 2025) | $190.055M | Slight decrease from $194.543M at Dec 31, 2024. |
| Unpaid Claims (Sep 30, 2025) | $140.457M | Decreased from $156.396M at Dec 31, 2024, reducing current liabilities. |
| Weighted Average Shares Outstanding (Q3 2025) | 512,743,521 | Increased from 490,180,103 in Q3 2024, indicating dilution. |
| Net Loss (YTD Sep 30, 2025) | $36.229M | Increased from $20.917M in YTD Sep 30, 2024. |
| SEC File Number | 001-39252 | Identifies the company's filing history with the SEC. |
| IRS Employer Identification No. | 98-1515192 | Company's tax identification number. |
| Net Loss (Q2 2025) | $25.3M | Improved from $50.1M net loss in Q2 2024, showing reduced losses. |
| Revenue (Q2 2025) | $350.5M | Increased 9.5% from $320.1M in Q2 2024, indicating top-line growth. |
| Accumulated Deficit | $1.55B | Increased from $1.52B at Dec 31, 2024, highlighting ongoing unprofitability. |
| Cash & Equivalents | $150.7M | Decreased from $180.3M at Dec 31, 2024, signaling cash burn. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Clover Health Investments, Corp. /De (CLOV)?
Clover Health Investments, Corp. /De has 45 recent SEC filings from Jan 2024 to May 2026, including 31 8-K, 7 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CLOV filings?
Across 45 filings, the sentiment breakdown is: 2 bearish, 42 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Clover Health Investments, Corp. /De SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Clover Health Investments, Corp. /De (CLOV) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Clover Health Investments, Corp. /De?
Key financial highlights from Clover Health Investments, Corp. /De's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for CLOV?
The investment thesis for CLOV includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Clover Health Investments, Corp. /De?
Key executives identified across Clover Health Investments, Corp. /De's filings include Andrew Toy, Peter Kuipers, Dr. David M. Gollaher, Dr. Andrew M. Wilson.
What are the main risk factors for Clover Health Investments, Corp. /De stock?
Of CLOV's 37 assessed filings, 2 were flagged high-risk, 17 medium-risk, and 18 low-risk.
What are recent predictions and forward guidance from Clover Health Investments, Corp. /De?
Forward guidance and predictions for Clover Health Investments, Corp. /De are extracted from SEC filings as they are enriched.